A
$ Value
$0
Shares
2,370
Price
$0
Filed
Jun 18
Insider
Name
Pangalos Menelas N
Title
—
CIK
0002001873
Roles
Director
Transaction Details
Transaction Date
2025-06-17
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,370
Footnotes
The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025.
Filing Info
Pangalos Menelas N's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | ABSI | A | $0 |
| 2026-03-02 | ABSI | A | $0 |
| 2026-02-27 | ABSI | ▲ | $206K |
| 2025-09-22 | ABSI | ▲ | $255K ★ |
| 2025-06-17 | BIIB | A | $0 |
| 2025-06-11 | ABSI | A | $0 |
| 2025-06-11 | ABSI | A | $0 |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Murphy Nicole
Head of Pharm Ops and Tech
|
$585 | — | 2026-02-13 |
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |